Congress hears from many over regulation of compounders

03/3/2013 | Washington Post, The

As Congress begins to consider changes in the regulation of specialty pharmacies, drugmakers are calling for oversight or limits for compounders that act as mass producers or make "knockoff" medications for humans and animals. Hospitals want to avoid regulations that exacerbate drug shortages.

View Full Article in:

Washington Post, The

Published in Brief: